{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-016986","form_type":"8-K","ticker":"NXPL","cik":"0001058307","company_name":"NextPlat Corp","filed_at":"2026-05-14T18:02:06+00:00","discovered_at":"2026-05-14T18:03:00.267953+00:00","generated_at":"2026-05-14T18:06:43.757982+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NextPlat Q1 revenue $9.9M, gross margin record 35%, net loss narrows 42% YoY","bullets":["Revenue $9.9M (down 29% YoY); consolidated gross margin record 35% vs 21% prior year.","Net loss $1.1M ($0.42/sh) vs loss $1.9M ($0.75) prior year, a 42% reduction.","Operating expenses down 9% to $4.5M; zero unsecured debt, $11.0M cash.","Healthcare contract revenue up 19% sequentially; five new 340B entities contracted.","e-Commerce secured $820K satellite IoT contract from UK/NATO; pipeline >$1.2M."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-016986","json":"https://secwatch.observer/filing/0001437749-26-016986.json","markdown":"https://secwatch.observer/filing/0001437749-26-016986.md","text":"https://secwatch.observer/filing/0001437749-26-016986.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1058307/000143774926016986/0001437749-26-016986-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1058307/000143774926016986/nxpl20260325_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T18:06:43.757982+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a252c136a9739418a46f066598b1ecff5294a988","claim":"NextPlat Corp reported the quarter ended March 31, 2026 results: revenue $9.9 million, net income approximately $1.1 million, EPS ($0.42) per diluted share.","evidence_excerpt":"Consolidated revenue for the quarter ended March 31, 2026, was approximately $9.9 million, compared to approximately $13.9 million for the prior year period, an overall decrease of 29% which reflects the expected decline in overall healthcare revenue.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1058307/000143774926016986/0001437749-26-016986-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2026"},{"label":"Revenue","value":"$9.9 million"},{"label":"Net income","value":"approximately $1.1 million"},{"label":"EPS","value":"($0.42) per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}